Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (Bfolfirinox-3) in Chemorefractory Metastatic Colorectal Cancer
Cancers（2021）
关键词
5-fluorouracil,irinotecan,oxaliplatin,bevacizumab,chemotherapy metastatic colorectal cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要